Genetic urogenital tract malformation

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:156622
Who is this for?
Show terms as
26Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Genetic urogenital tract malformation is a broad category of rare congenital anomalies affecting the urinary and genital systems that arise due to underlying genetic causes. These malformations encompass a wide spectrum of structural abnormalities involving the kidneys, ureters, bladder, urethra, and genital organs, which develop during embryonic life due to disruptions in the normal developmental pathways of the urogenital system. The severity can range from mild anomalies that may be incidentally discovered to severe malformations that significantly impair renal function or reproductive capacity. Clinical features vary widely depending on the specific structures involved and may include renal agenesis or dysplasia, hydronephrosis, vesicoureteral reflux, hypospadias, cryptorchidism, uterine malformations, or ambiguous genitalia. Many of these conditions are detected prenatally through ultrasound or become apparent in the neonatal period. Some cases are isolated findings, while others occur as part of broader genetic syndromes involving multiple organ systems. The genetic basis is heterogeneous, involving numerous genes critical to urogenital development, and may follow various inheritance patterns depending on the specific underlying genetic defect. Treatment is individualized based on the specific malformation and may include surgical correction, management of renal function, hormonal therapy, or supportive care. Long-term follow-up with nephrology, urology, and genetics specialists is often recommended to monitor for complications such as chronic kidney disease or reproductive difficulties.

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

FDA & Trial Timeline

9 events
Dec 2025Evaluation of Well Being and Patient Reported Outcomes After Robotic Single-port Nipple Sparing Mastectomy and Implant Reconstruction

Beaumont Hospital — NA

TrialNOT YET RECRUITING
Jun 2025The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI

Georgetown University — NA

TrialRECRUITING
May 2024Clinical Study of External Electrical Stimulation for Male Incontinence

Elidah, Inc. — NA

TrialACTIVE NOT RECRUITING
Jun 2021CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing

Georgetown University — NA

TrialRECRUITING
Jan 2021Study on Early Genetic Screening and Precise Strategy of Neonatal Critical Illness

Children's Hospital of Fudan University

TrialRECRUITING
Oct 2019Von Willebrand Factor in Pregnancy (VIP) Study

University of Washington

TrialRECRUITING
May 2016Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations

M.D. Anderson Cancer Center — NA

TrialACTIVE NOT RECRUITING
Mar 2016Women at Risk of Breast Cancer and OLFM4

Institut Cancerologie de l'Ouest — NA

TrialACTIVE NOT RECRUITING
Mar 2011Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry

University of Kansas Medical Center

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Genetic urogenital tract malformation.

View clinical trials →

No actively recruiting trials found for Genetic urogenital tract malformation at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Genetic urogenital tract malformation community →

Specialists

Showing 25 of 26View all specialists →
MI
Meredith S Irwin
CINCINNATI, OH
Specialist
PI on 1 active trial
PM
Paul Martin
Specialist
PI on 3 active trials73 Genetic urogenital tract malformation publications
PM
Patricia Bretones, MD
Specialist
PI on 1 active trial
FP
Frank Czerwiec, M.D., Ph.D.
ROCKVILLE, MD
Specialist
PI on 2 active trials
LP
Lise Duranteau, MD, PhD
Specialist
PI on 1 active trial
MM
Manish Sinha, PhD, MRCP (UK), MRCPCH
SPOKANE, WA
Specialist
PI on 1 active trial
CP
Claus H Gravholt, Professor
Specialist
PI on 2 active trials
JM
Jose Rauh-Hain, MD,MPH
HOUSTON, TX
Specialist
PI on 1 active trial
MM
Morey W Haymond, MD
HOUSTON, TX
Specialist
PI on 1 active trial
RM
Robert B. Montgomery, MD
Specialist
PI on 2 active trials
MM
Maneesh Jain, MD
WASHINGTON, DC
Specialist
PI on 1 active trial
PM
Phoebe Tsao, MD MSc
ANN ARBOR, MI
Specialist
PI on 1 active trial
RM
Ryan Burri, MD
BAY PINES, FL
Specialist
PI on 1 active trial
RF
Rosalind A Eeles, FRCP FRCR
Specialist
PI on 2 active trials
JM
Joan J Khoo, MRCP
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Genetic urogenital tract malformation.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Genetic urogenital tract malformationForum →

No community posts yet. Be the first to share your experience with Genetic urogenital tract malformation.

Start the conversation →

Latest news about Genetic urogenital tract malformation

Disease timeline:

New recruiting trial: Study on Early Genetic Screening and Precise Strategy of Neonatal Critical Illness

A new clinical trial is recruiting patients for Genetic urogenital tract malformation

New recruiting trial: Diagnosis and Management of Intrauterine Growth Restriction and Congenital Anomalies

A new clinical trial is recruiting patients for Genetic urogenital tract malformation

New recruiting trial: Von Willebrand Factor in Pregnancy (VIP) Study

A new clinical trial is recruiting patients for Genetic urogenital tract malformation

New recruiting trial: The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI

A new clinical trial is recruiting patients for Genetic urogenital tract malformation

New recruiting trial: Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry

A new clinical trial is recruiting patients for Genetic urogenital tract malformation

New recruiting trial: CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing

A new clinical trial is recruiting patients for Genetic urogenital tract malformation

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Genetic urogenital tract malformation

What is Genetic urogenital tract malformation?

Genetic urogenital tract malformation is a broad category of rare congenital anomalies affecting the urinary and genital systems that arise due to underlying genetic causes. These malformations encompass a wide spectrum of structural abnormalities involving the kidneys, ureters, bladder, urethra, and genital organs, which develop during embryonic life due to disruptions in the normal developmental pathways of the urogenital system. The severity can range from mild anomalies that may be incidentally discovered to severe malformations that significantly impair renal function or reproductive capa

At what age does Genetic urogenital tract malformation typically begin?

Typical onset of Genetic urogenital tract malformation is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Genetic urogenital tract malformation?

25 specialists and care centers treating Genetic urogenital tract malformation are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.